Amazon puts selling pharmaceuticals plan on back-burner
April 17, 2018Manufacturing and Production, Sales and Marketing amazon, biotech, drugs, pharma, pharmaceutical, pharmacy
Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small …
Keytruda success continues, beating Opdivo in lung cancer survival
April 17, 2018Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma
Not content with revealing two strong waves of data on its flagship immunotherapy Keytruda (pembrolizumab) over the past weeks, MSD …
Frequency Therapeutics hires industry vet
April 16, 2018Manufacturing and Production, Medical Communications Frequency Therapeutics, biotech, drugs, pharma, pharmaceutical
Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …
Care packaging: Inside the Falsified Medicines Directive
April 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, packaging, pharma, pharmaceutical
When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …
Novartis’ Entresto helps preserve kidney function in chronic heart failure patients
April 16, 2018Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma
Novartis has lifted the curtain on new data from a Phase 3 trial investigating the efficacy of Entresto (sacubitril/valsartan) in …
Sanofi looks to trim down with divestments
April 16, 2018Sales and Marketing Charterhouse Capital, Sanofi, Zentiva, biotech, drugs, pharma, pharmaceutical
Sanofi has begun part of a larger process of slimming down its business with the sales of 12 medicines. It …
J&J’s ketamine nasal spray for depression continues to impress
April 16, 2018Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical
New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
Keytruda continues success with new Phase 3 data in adjuvant melanoma
April 16, 2018Research and Development, Sales and Marketing Cancer, MSD, keytruda, melanoma, pharma, skinc cancer
MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …
Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal
April 16, 2018Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …
Visit Us! DIA’s Refreshed Homepage Design
April 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
We’re excited to share with you our recently redesigned homepage, at the same site address: DIAglobal.org. The main objectives of …
PrimeVigilance celebrates its 10th anniversary
April 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance
PrimeVigilance will be exhibiting and celebrating its 10th anniversary at #DIAEurope2018, raffling 10 bottles of champagne away! Stop by their …
Top Ten most popular articles on Pharmafile.com this week
April 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Cancer, Humira, Mylan, Novartis, Shire, Takeda, Teva, acquisition, cystic fibrosis, hepatitis C, pharma, top ten
It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …
Hanmi terminates lung cancer drug after being muscled out by AZ’s Tagrisso
April 13, 2018Medical Communications, Research and Development AstraZeneca, Cancer, Otila, Tagrisso, hanmi, lung cancer, pharma
South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it …
Evolutionary path of kidney cancer tracked, “born to be bad” type discovered
April 13, 2018Medical Communications, Research and Development Kidney cancer, biotech, drugs, pharma, pharmaceutical
A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …
Eisai forms partnership to find new tuberculosis treatment
April 13, 2018Medical Communications, Research and Development Colorado State University, Eisai, broad institute, pharma, tuberculosis, university of chicago
Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …
Roche’s immunotherapy lucky streak ends with deaths in trial
April 13, 2018Medical Communications, Research and Development Exelixis, Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …
Wickham Labs Announces Upcoming Webinar on Regulatory Changes in Medical Device Development
April 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories
Come join Wickham Laboratories and Patient Guard for this free webinar on May 23rd to discuss Regulatory Changes in Medical …
Ipsen bolsters executive leadership with two new recruits
April 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma
Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …
New hepatitis C combo boasts 97% cure rate for just $300
April 12, 2018Research and Development AbbVie, DNDi, Drugs for Neglected Diseases initiative, Gilead, HCV, Pharco Pharmaceuticals, hepatitis C, pharma, sovaldi
A partnership of the not-for-profit organisation Drugs for Neglected Diseases initiative (DNDi) and Egyptian drug firm Pharco Pharmaceuticals is working …
EMA announces second-ever public hearing on high-use antibiotics
April 12, 2018Medical Communications Antibiotics, EMA, biotech, drugs, pharma, pharmaceutical
The EMA has announced, following the first-ever public hearing on valproate, that it would hold a second public hearing regarding …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
